Click for best price
Hepatitis B Human Immunoglobulin Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Hepatitis B Human Immunoglobulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Human Immunoglobulin. This report contains market size and forecasts of Hepatitis B Human Immunoglobulin in global, including the following market information:
Global Hepatitis B Human Immunoglobulin Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Hepatitis B Human Immunoglobulin Market Sales, 2018-2023, 2024-2030, (Litre)
Global top five Hepatitis B Human Immunoglobulin companies in 2022 (%)
The global Hepatitis B Human Immunoglobulin market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
100IU Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hepatitis B Human Immunoglobulin include Biotest, ADMA Biologics, Sanquin Blood, Bio Products Laboratory, Baxter, CSL, Bayer, Grifols and Octapharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis B Human Immunoglobulin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B Human Immunoglobulin Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (Litre)
Global Hepatitis B Human Immunoglobulin Market Segment Percentages, by Type, 2022 (%)
100IU
200IU
400IU
Global Hepatitis B Human Immunoglobulin Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (Litre)
Global Hepatitis B Human Immunoglobulin Market Segment Percentages, by Application, 2022 (%)
Measles Prevention
Prevention of Hepatitis B Virus Infection
Hepatitis A Virus Infection
Other
Global Hepatitis B Human Immunoglobulin Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (Litre)
Global Hepatitis B Human Immunoglobulin Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis B Human Immunoglobulin revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hepatitis B Human Immunoglobulin revenues share in global market, 2022 (%)
Key companies Hepatitis B Human Immunoglobulin sales in global market, 2018-2023 (Estimated), (Litre)
Key companies Hepatitis B Human Immunoglobulin sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biotest
ADMA Biologics
Sanquin Blood
Bio Products Laboratory
Baxter
CSL
Bayer
Grifols
Octapharma
Hualan Biological
China Biologic
Tiantan Biologic
Shuanglin Bio-pharmacy
Sichuan Yuanda Shuyang
Shanghai Institute of Biological
Hualan
Shanghai RAAS Blood Products
China Grand Enterprises
Nanyue Biopharmaceutical
Boya Biopharmaceutical Group
Tonglu Biopharmaceutical
Shandong Taibang Biopharmaceutical
Guangdong Shuanglin Biopharmaceutical
Chengdu Rongsheng Pharmaceutical
Shenzhen Weiguang Biopharmaceutical
Green Cross (China) Biological Products
Sinopharm
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatitis B Human Immunoglobulin, market overview.
Chapter 2: Global Hepatitis B Human Immunoglobulin market size in revenue and volume.
Chapter 3: Detailed analysis of Hepatitis B Human Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatitis B Human Immunoglobulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hepatitis B Human Immunoglobulin capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Hepatitis B Human Immunoglobulin Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
123 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hepatitis B Human Immunoglobulin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis B Human Immunoglobulin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis B Human Immunoglobulin Overall Market Size
2.1 Global Hepatitis B Human Immunoglobulin Market Size: 2022 VS 2030
2.2 Global Hepatitis B Human Immunoglobulin Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Hepatitis B Human Immunoglobulin Sales: 2018-2030
3 Company Landscape
3.1 Top Hepatitis B Human Immunoglobulin Players in Global Market
3.2 Top Global Hepatitis B Human Immunoglobulin Companies Ranked by Revenue
3.3 Global Hepatitis B Human Immunoglobulin Revenue by Companies
3.4 Global Hepatitis B Human Immunoglobulin Sales by Companies
3.5 Global Hepatitis B Human Immunoglobulin Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hepatitis B Human Immunoglobulin Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hepatitis B Human Immunoglobulin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatitis B Human Immunoglobulin Players in Global Market
3.8.1 List of Global Tier 1 Hepatitis B Human Immunoglobulin Companies
3.8.2 List of Global Tier 2 and Tier 3 Hepatitis B Human Immunoglobulin Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hepatitis B Human Immunoglobulin Market Size Markets, 2022 & 2030
4.1.2 100IU
4.1.3 200IU
4.1.4 400IU
4.2 By Type - Global Hepatitis B Human Immunoglobulin Revenue & Forecasts
4.2.1 By Type - Global Hepatitis B Human Immunoglobulin Revenue, 2018-2023
4.2.2 By Type - Global Hepatitis B Human Immunoglobulin Revenue, 2024-2030
4.2.3 By Type - Global Hepatitis B Human Immunoglobulin Revenue Market Share, 2018-2030
4.3 By Type - Global Hepatitis B Human Immunoglobulin Sales & Forecasts
4.3.1 By Type - Global Hepatitis B Human Immunoglobulin Sales, 2018-2023
4.3.2 By Type - Global Hepatitis B Human Immunoglobulin Sales, 2024-2030
4.3.3 By Type - Global Hepatitis B Human Immunoglobulin Sales Market Share, 2018-2030
4.4 By Type - Global Hepatitis B Human Immunoglobulin Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatitis B Human Immunoglobulin Market Size, 2022 & 2030
5.1.2 Measles Prevention
5.1.3 Prevention of Hepatitis B Virus Infection
5.1.4 Hepatitis A Virus Infection
5.1.5 Other
5.2 By Application - Global Hepatitis B Human Immunoglobulin Revenue & Forecasts
5.2.1 By Application - Global Hepatitis B Human Immunoglobulin Revenue, 2018-2023
5.2.2 By Application - Global Hepatitis B Human Immunoglobulin Revenue, 2024-2030
5.2.3 By Application - Global Hepatitis B Human Immunoglobulin Revenue Market Share, 2018-2030
5.3 By Application - Global Hepatitis B Human Immunoglobulin Sales & Forecasts
5.3.1 By Application - Global Hepatitis B Human Immunoglobulin Sales, 2018-2023
5.3.2 By Application - Global Hepatitis B Human Immunoglobulin Sales, 2024-2030
5.3.3 By Application - Global Hepatitis B Human Immunoglobulin Sales Market Share, 2018-2030
5.4 By Application - Global Hepatitis B Human Immunoglobulin Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Hepatitis B Human Immunoglobulin Market Size, 2022 & 2030
6.2 By Region - Global Hepatitis B Human Immunoglobulin Revenue & Forecasts
6.2.1 By Region - Global Hepatitis B Human Immunoglobulin Revenue, 2018-2023
6.2.2 By Region - Global Hepatitis B Human Immunoglobulin Revenue, 2024-2030
6.2.3 By Region - Global Hepatitis B Human Immunoglobulin Revenue Market Share, 2018-2030
6.3 By Region - Global Hepatitis B Human Immunoglobulin Sales & Forecasts
6.3.1 By Region - Global Hepatitis B Human Immunoglobulin Sales, 2018-2023
6.3.2 By Region - Global Hepatitis B Human Immunoglobulin Sales, 2024-2030
6.3.3 By Region - Global Hepatitis B Human Immunoglobulin Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Hepatitis B Human Immunoglobulin Revenue, 2018-2030
6.4.2 By Country - North America Hepatitis B Human Immunoglobulin Sales, 2018-2030
6.4.3 US Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.4.4 Canada Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.4.5 Mexico Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Hepatitis B Human Immunoglobulin Revenue, 2018-2030
6.5.2 By Country - Europe Hepatitis B Human Immunoglobulin Sales, 2018-2030
6.5.3 Germany Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.5.4 France Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.5.5 U.K. Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.5.6 Italy Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.5.7 Russia Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.5.8 Nordic Countries Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.5.9 Benelux Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Hepatitis B Human Immunoglobulin Revenue, 2018-2030
6.6.2 By Region - Asia Hepatitis B Human Immunoglobulin Sales, 2018-2030
6.6.3 China Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.6.4 Japan Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.6.5 South Korea Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.6.6 Southeast Asia Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.6.7 India Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Hepatitis B Human Immunoglobulin Revenue, 2018-2030
6.7.2 By Country - South America Hepatitis B Human Immunoglobulin Sales, 2018-2030
6.7.3 Brazil Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.7.4 Argentina Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hepatitis B Human Immunoglobulin Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Hepatitis B Human Immunoglobulin Sales, 2018-2030
6.8.3 Turkey Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.8.4 Israel Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.8.5 Saudi Arabia Hepatitis B Human Immunoglobulin Market Size, 2018-2030
6.8.6 UAE Hepatitis B Human Immunoglobulin Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Biotest
7.1.1 Biotest Company Summary
7.1.2 Biotest Business Overview
7.1.3 Biotest Hepatitis B Human Immunoglobulin Major Product Offerings
7.1.4 Biotest Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.1.5 Biotest Key News & Latest Developments
7.2 ADMA Biologics
7.2.1 ADMA Biologics Company Summary
7.2.2 ADMA Biologics Business Overview
7.2.3 ADMA Biologics Hepatitis B Human Immunoglobulin Major Product Offerings
7.2.4 ADMA Biologics Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.2.5 ADMA Biologics Key News & Latest Developments
7.3 Sanquin Blood
7.3.1 Sanquin Blood Company Summary
7.3.2 Sanquin Blood Business Overview
7.3.3 Sanquin Blood Hepatitis B Human Immunoglobulin Major Product Offerings
7.3.4 Sanquin Blood Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.3.5 Sanquin Blood Key News & Latest Developments
7.4 Bio Products Laboratory
7.4.1 Bio Products Laboratory Company Summary
7.4.2 Bio Products Laboratory Business Overview
7.4.3 Bio Products Laboratory Hepatitis B Human Immunoglobulin Major Product Offerings
7.4.4 Bio Products Laboratory Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.4.5 Bio Products Laboratory Key News & Latest Developments
7.5 Baxter
7.5.1 Baxter Company Summary
7.5.2 Baxter Business Overview
7.5.3 Baxter Hepatitis B Human Immunoglobulin Major Product Offerings
7.5.4 Baxter Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.5.5 Baxter Key News & Latest Developments
7.6 CSL
7.6.1 CSL Company Summary
7.6.2 CSL Business Overview
7.6.3 CSL Hepatitis B Human Immunoglobulin Major Product Offerings
7.6.4 CSL Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.6.5 CSL Key News & Latest Developments
7.7 Bayer
7.7.1 Bayer Company Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Hepatitis B Human Immunoglobulin Major Product Offerings
7.7.4 Bayer Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.7.5 Bayer Key News & Latest Developments
7.8 Grifols
7.8.1 Grifols Company Summary
7.8.2 Grifols Business Overview
7.8.3 Grifols Hepatitis B Human Immunoglobulin Major Product Offerings
7.8.4 Grifols Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.8.5 Grifols Key News & Latest Developments
7.9 Octapharma
7.9.1 Octapharma Company Summary
7.9.2 Octapharma Business Overview
7.9.3 Octapharma Hepatitis B Human Immunoglobulin Major Product Offerings
7.9.4 Octapharma Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.9.5 Octapharma Key News & Latest Developments
7.10 Hualan Biological
7.10.1 Hualan Biological Company Summary
7.10.2 Hualan Biological Business Overview
7.10.3 Hualan Biological Hepatitis B Human Immunoglobulin Major Product Offerings
7.10.4 Hualan Biological Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.10.5 Hualan Biological Key News & Latest Developments
7.11 China Biologic
7.11.1 China Biologic Company Summary
7.11.2 China Biologic Hepatitis B Human Immunoglobulin Business Overview
7.11.3 China Biologic Hepatitis B Human Immunoglobulin Major Product Offerings
7.11.4 China Biologic Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.11.5 China Biologic Key News & Latest Developments
7.12 Tiantan Biologic
7.12.1 Tiantan Biologic Company Summary
7.12.2 Tiantan Biologic Hepatitis B Human Immunoglobulin Business Overview
7.12.3 Tiantan Biologic Hepatitis B Human Immunoglobulin Major Product Offerings
7.12.4 Tiantan Biologic Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.12.5 Tiantan Biologic Key News & Latest Developments
7.13 Shuanglin Bio-pharmacy
7.13.1 Shuanglin Bio-pharmacy Company Summary
7.13.2 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Business Overview
7.13.3 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Major Product Offerings
7.13.4 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.13.5 Shuanglin Bio-pharmacy Key News & Latest Developments
7.14 Sichuan Yuanda Shuyang
7.14.1 Sichuan Yuanda Shuyang Company Summary
7.14.2 Sichuan Yuanda Shuyang Business Overview
7.14.3 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Major Product Offerings
7.14.4 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.14.5 Sichuan Yuanda Shuyang Key News & Latest Developments
7.15 Shanghai Institute of Biological
7.15.1 Shanghai Institute of Biological Company Summary
7.15.2 Shanghai Institute of Biological Business Overview
7.15.3 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Major Product Offerings
7.15.4 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.15.5 Shanghai Institute of Biological Key News & Latest Developments
7.16 Hualan
7.16.1 Hualan Company Summary
7.16.2 Hualan Business Overview
7.16.3 Hualan Hepatitis B Human Immunoglobulin Major Product Offerings
7.16.4 Hualan Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.16.5 Hualan Key News & Latest Developments
7.17 Shanghai RAAS Blood Products
7.17.1 Shanghai RAAS Blood Products Company Summary
7.17.2 Shanghai RAAS Blood Products Business Overview
7.17.3 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Major Product Offerings
7.17.4 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.17.5 Shanghai RAAS Blood Products Key News & Latest Developments
7.18 China Grand Enterprises
7.18.1 China Grand Enterprises Company Summary
7.18.2 China Grand Enterprises Business Overview
7.18.3 China Grand Enterprises Hepatitis B Human Immunoglobulin Major Product Offerings
7.18.4 China Grand Enterprises Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.18.5 China Grand Enterprises Key News & Latest Developments
7.19 Nanyue Biopharmaceutical
7.19.1 Nanyue Biopharmaceutical Company Summary
7.19.2 Nanyue Biopharmaceutical Business Overview
7.19.3 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Major Product Offerings
7.19.4 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.19.5 Nanyue Biopharmaceutical Key News & Latest Developments
7.20 Boya Biopharmaceutical Group
7.20.1 Boya Biopharmaceutical Group Company Summary
7.20.2 Boya Biopharmaceutical Group Business Overview
7.20.3 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Major Product Offerings
7.20.4 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.20.5 Boya Biopharmaceutical Group Key News & Latest Developments
7.21 Tonglu Biopharmaceutical
7.21.1 Tonglu Biopharmaceutical Company Summary
7.21.2 Tonglu Biopharmaceutical Business Overview
7.21.3 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Major Product Offerings
7.21.4 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.21.5 Tonglu Biopharmaceutical Key News & Latest Developments
7.22 Shandong Taibang Biopharmaceutical
7.22.1 Shandong Taibang Biopharmaceutical Company Summary
7.22.2 Shandong Taibang Biopharmaceutical Business Overview
7.22.3 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Major Product Offerings
7.22.4 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.22.5 Shandong Taibang Biopharmaceutical Key News & Latest Developments
7.23 Guangdong Shuanglin Biopharmaceutical
7.23.1 Guangdong Shuanglin Biopharmaceutical Company Summary
7.23.2 Guangdong Shuanglin Biopharmaceutical Business Overview
7.23.3 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Major Product Offerings
7.23.4 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.23.5 Guangdong Shuanglin Biopharmaceutical Key News & Latest Developments
7.24 Chengdu Rongsheng Pharmaceutical
7.24.1 Chengdu Rongsheng Pharmaceutical Company Summary
7.24.2 Chengdu Rongsheng Pharmaceutical Business Overview
7.24.3 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Major Product Offerings
7.24.4 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.24.5 Chengdu Rongsheng Pharmaceutical Key News & Latest Developments
7.25 Shenzhen Weiguang Biopharmaceutical
7.25.1 Shenzhen Weiguang Biopharmaceutical Company Summary
7.25.2 Shenzhen Weiguang Biopharmaceutical Business Overview
7.25.3 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Major Product Offerings
7.25.4 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.25.5 Shenzhen Weiguang Biopharmaceutical Key News & Latest Developments
7.26 Green Cross (China) Biological Products
7.26.1 Green Cross (China) Biological Products Company Summary
7.26.2 Green Cross (China) Biological Products Business Overview
7.26.3 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Major Product Offerings
7.26.4 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.26.5 Green Cross (China) Biological Products Key News & Latest Developments
7.27 Sinopharm
7.27.1 Sinopharm Company Summary
7.27.2 Sinopharm Business Overview
7.27.3 Sinopharm Hepatitis B Human Immunoglobulin Major Product Offerings
7.27.4 Sinopharm Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2018-2023)
7.27.5 Sinopharm Key News & Latest Developments
8 Global Hepatitis B Human Immunoglobulin Production Capacity, Analysis
8.1 Global Hepatitis B Human Immunoglobulin Production Capacity, 2018-2030
8.2 Hepatitis B Human Immunoglobulin Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatitis B Human Immunoglobulin Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hepatitis B Human Immunoglobulin Supply Chain Analysis
10.1 Hepatitis B Human Immunoglobulin Industry Value Chain
10.2 Hepatitis B Human Immunoglobulin Upstream Market
10.3 Hepatitis B Human Immunoglobulin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hepatitis B Human Immunoglobulin Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Hepatitis B Human Immunoglobulin in Global Market
Table 2. Top Hepatitis B Human Immunoglobulin Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Hepatitis B Human Immunoglobulin Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Hepatitis B Human Immunoglobulin Revenue Share by Companies, 2018-2023
Table 5. Global Hepatitis B Human Immunoglobulin Sales by Companies, (Litre), 2018-2023
Table 6. Global Hepatitis B Human Immunoglobulin Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Hepatitis B Human Immunoglobulin Price (2018-2023) & (US$/ML)
Table 8. Global Manufacturers Hepatitis B Human Immunoglobulin Product Type
Table 9. List of Global Tier 1 Hepatitis B Human Immunoglobulin Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis B Human Immunoglobulin Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Hepatitis B Human Immunoglobulin Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Hepatitis B Human Immunoglobulin Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Hepatitis B Human Immunoglobulin Sales (Litre), 2018-2023
Table 15. By Type - Global Hepatitis B Human Immunoglobulin Sales (Litre), 2024-2030
Table 16. By Application ? Global Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Hepatitis B Human Immunoglobulin Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Hepatitis B Human Immunoglobulin Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Hepatitis B Human Immunoglobulin Sales (Litre), 2018-2023
Table 20. By Application - Global Hepatitis B Human Immunoglobulin Sales (Litre), 2024-2030
Table 21. By Region ? Global Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Hepatitis B Human Immunoglobulin Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Hepatitis B Human Immunoglobulin Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Hepatitis B Human Immunoglobulin Sales (Litre), 2018-2023
Table 25. By Region - Global Hepatitis B Human Immunoglobulin Sales (Litre), 2024-2030
Table 26. By Country - North America Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Hepatitis B Human Immunoglobulin Sales, (Litre), 2018-2023
Table 29. By Country - North America Hepatitis B Human Immunoglobulin Sales, (Litre), 2024-2030
Table 30. By Country - Europe Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Hepatitis B Human Immunoglobulin Sales, (Litre), 2018-2023
Table 33. By Country - Europe Hepatitis B Human Immunoglobulin Sales, (Litre), 2024-2030
Table 34. By Region - Asia Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Hepatitis B Human Immunoglobulin Sales, (Litre), 2018-2023
Table 37. By Region - Asia Hepatitis B Human Immunoglobulin Sales, (Litre), 2024-2030
Table 38. By Country - South America Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Hepatitis B Human Immunoglobulin Sales, (Litre), 2018-2023
Table 41. By Country - South America Hepatitis B Human Immunoglobulin Sales, (Litre), 2024-2030
Table 42. By Country - Middle East & Africa Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Hepatitis B Human Immunoglobulin Sales, (Litre), 2018-2023
Table 45. By Country - Middle East & Africa Hepatitis B Human Immunoglobulin Sales, (Litre), 2024-2030
Table 46. Biotest Company Summary
Table 47. Biotest Hepatitis B Human Immunoglobulin Product Offerings
Table 48. Biotest Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 49. Biotest Key News & Latest Developments
Table 50. ADMA Biologics Company Summary
Table 51. ADMA Biologics Hepatitis B Human Immunoglobulin Product Offerings
Table 52. ADMA Biologics Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 53. ADMA Biologics Key News & Latest Developments
Table 54. Sanquin Blood Company Summary
Table 55. Sanquin Blood Hepatitis B Human Immunoglobulin Product Offerings
Table 56. Sanquin Blood Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 57. Sanquin Blood Key News & Latest Developments
Table 58. Bio Products Laboratory Company Summary
Table 59. Bio Products Laboratory Hepatitis B Human Immunoglobulin Product Offerings
Table 60. Bio Products Laboratory Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 61. Bio Products Laboratory Key News & Latest Developments
Table 62. Baxter Company Summary
Table 63. Baxter Hepatitis B Human Immunoglobulin Product Offerings
Table 64. Baxter Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 65. Baxter Key News & Latest Developments
Table 66. CSL Company Summary
Table 67. CSL Hepatitis B Human Immunoglobulin Product Offerings
Table 68. CSL Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 69. CSL Key News & Latest Developments
Table 70. Bayer Company Summary
Table 71. Bayer Hepatitis B Human Immunoglobulin Product Offerings
Table 72. Bayer Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 73. Bayer Key News & Latest Developments
Table 74. Grifols Company Summary
Table 75. Grifols Hepatitis B Human Immunoglobulin Product Offerings
Table 76. Grifols Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 77. Grifols Key News & Latest Developments
Table 78. Octapharma Company Summary
Table 79. Octapharma Hepatitis B Human Immunoglobulin Product Offerings
Table 80. Octapharma Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 81. Octapharma Key News & Latest Developments
Table 82. Hualan Biological Company Summary
Table 83. Hualan Biological Hepatitis B Human Immunoglobulin Product Offerings
Table 84. Hualan Biological Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 85. Hualan Biological Key News & Latest Developments
Table 86. China Biologic Company Summary
Table 87. China Biologic Hepatitis B Human Immunoglobulin Product Offerings
Table 88. China Biologic Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 89. China Biologic Key News & Latest Developments
Table 90. Tiantan Biologic Company Summary
Table 91. Tiantan Biologic Hepatitis B Human Immunoglobulin Product Offerings
Table 92. Tiantan Biologic Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 93. Tiantan Biologic Key News & Latest Developments
Table 94. Shuanglin Bio-pharmacy Company Summary
Table 95. Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Product Offerings
Table 96. Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 97. Shuanglin Bio-pharmacy Key News & Latest Developments
Table 98. Sichuan Yuanda Shuyang Company Summary
Table 99. Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Product Offerings
Table 100. Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 101. Sichuan Yuanda Shuyang Key News & Latest Developments
Table 102. Shanghai Institute of Biological Company Summary
Table 103. Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Product Offerings
Table 104. Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 105. Shanghai Institute of Biological Key News & Latest Developments
Table 106. Hualan Company Summary
Table 107. Hualan Hepatitis B Human Immunoglobulin Product Offerings
Table 108. Hualan Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 109. Hualan Key News & Latest Developments
Table 110. Shanghai RAAS Blood Products Company Summary
Table 111. Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Product Offerings
Table 112. Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 113. Shanghai RAAS Blood Products Key News & Latest Developments
Table 114. China Grand Enterprises Company Summary
Table 115. China Grand Enterprises Hepatitis B Human Immunoglobulin Product Offerings
Table 116. China Grand Enterprises Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 117. China Grand Enterprises Key News & Latest Developments
Table 118. Nanyue Biopharmaceutical Company Summary
Table 119. Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Product Offerings
Table 120. Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 121. Nanyue Biopharmaceutical Key News & Latest Developments
Table 122. Boya Biopharmaceutical Group Company Summary
Table 123. Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Product Offerings
Table 124. Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 125. Boya Biopharmaceutical Group Key News & Latest Developments
Table 126. Tonglu Biopharmaceutical Company Summary
Table 127. Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Product Offerings
Table 128. Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 129. Tonglu Biopharmaceutical Key News & Latest Developments
Table 130. Shandong Taibang Biopharmaceutical Company Summary
Table 131. Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Product Offerings
Table 132. Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 133. Shandong Taibang Biopharmaceutical Key News & Latest Developments
Table 134. Guangdong Shuanglin Biopharmaceutical Company Summary
Table 135. Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Product Offerings
Table 136. Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 137. Guangdong Shuanglin Biopharmaceutical Key News & Latest Developments
Table 138. Chengdu Rongsheng Pharmaceutical Company Summary
Table 139. Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Product Offerings
Table 140. Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 141. Chengdu Rongsheng Pharmaceutical Key News & Latest Developments
Table 142. Shenzhen Weiguang Biopharmaceutical Company Summary
Table 143. Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Product Offerings
Table 144. Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 145. Shenzhen Weiguang Biopharmaceutical Key News & Latest Developments
Table 146. Green Cross (China) Biological Products Company Summary
Table 147. Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Product Offerings
Table 148. Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 149. Green Cross (China) Biological Products Key News & Latest Developments
Table 150. Sinopharm Company Summary
Table 151. Sinopharm Hepatitis B Human Immunoglobulin Product Offerings
Table 152. Sinopharm Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2018-2023)
Table 153. Sinopharm Key News & Latest Developments
Table 154. Hepatitis B Human Immunoglobulin Production Capacity (Litre) of Key Manufacturers in Global Market, 2021-2023 (Litre)
Table 155. Global Hepatitis B Human Immunoglobulin Capacity Market Share of Key Manufacturers, 2021-2023
Table 156. Global Hepatitis B Human Immunoglobulin Production by Region, 2018-2023 (Litre)
Table 157. Global Hepatitis B Human Immunoglobulin Production by Region, 2024-2030 (Litre)
Table 158. Hepatitis B Human Immunoglobulin Market Opportunities & Trends in Global Market
Table 159. Hepatitis B Human Immunoglobulin Market Drivers in Global Market
Table 160. Hepatitis B Human Immunoglobulin Market Restraints in Global Market
Table 161. Hepatitis B Human Immunoglobulin Raw Materials
Table 162. Hepatitis B Human Immunoglobulin Raw Materials Suppliers in Global Market
Table 163. Typical Hepatitis B Human Immunoglobulin Downstream
Table 164. Hepatitis B Human Immunoglobulin Downstream Clients in Global Market
Table 165. Hepatitis B Human Immunoglobulin Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hepatitis B Human Immunoglobulin Segment by Type in 2022
Figure 2. Hepatitis B Human Immunoglobulin Segment by Application in 2022
Figure 3. Global Hepatitis B Human Immunoglobulin Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hepatitis B Human Immunoglobulin Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Hepatitis B Human Immunoglobulin Revenue, 2018-2030 (US$, Mn)
Figure 7. Hepatitis B Human Immunoglobulin Sales in Global Market: 2018-2030 (Litre)
Figure 8. The Top 3 and 5 Players Market Share by Hepatitis B Human Immunoglobulin Revenue in 2022
Figure 9. By Type - Global Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Hepatitis B Human Immunoglobulin Revenue Market Share, 2018-2030
Figure 11. By Type - Global Hepatitis B Human Immunoglobulin Sales Market Share, 2018-2030
Figure 12. By Type - Global Hepatitis B Human Immunoglobulin Price (US$/ML), 2018-2030
Figure 13. By Application - Global Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Hepatitis B Human Immunoglobulin Revenue Market Share, 2018-2030
Figure 15. By Application - Global Hepatitis B Human Immunoglobulin Sales Market Share, 2018-2030
Figure 16. By Application - Global Hepatitis B Human Immunoglobulin Price (US$/ML), 2018-2030
Figure 17. By Region - Global Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Hepatitis B Human Immunoglobulin Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Hepatitis B Human Immunoglobulin Revenue Market Share, 2018-2030
Figure 20. By Region - Global Hepatitis B Human Immunoglobulin Sales Market Share, 2018-2030
Figure 21. By Country - North America Hepatitis B Human Immunoglobulin Revenue Market Share, 2018-2030
Figure 22. By Country - North America Hepatitis B Human Immunoglobulin Sales Market Share, 2018-2030
Figure 23. US Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Hepatitis B Human Immunoglobulin Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Hepatitis B Human Immunoglobulin Sales Market Share, 2018-2030
Figure 28. Germany Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 29. France Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Hepatitis B Human Immunoglobulin Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Hepatitis B Human Immunoglobulin Sales Market Share, 2018-2030
Figure 37. China Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 41. India Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Hepatitis B Human Immunoglobulin Revenue Market Share, 2018-2030
Figure 43. By Country - South America Hepatitis B Human Immunoglobulin Sales Market Share, 2018-2030
Figure 44. Brazil Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Hepatitis B Human Immunoglobulin Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Hepatitis B Human Immunoglobulin Sales Market Share, 2018-2030
Figure 48. Turkey Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2018-2030
Figure 52. Global Hepatitis B Human Immunoglobulin Production Capacity (Litre), 2018-2030
Figure 53. The Percentage of Production Hepatitis B Human Immunoglobulin by Region, 2022 VS 2030
Figure 54. Hepatitis B Human Immunoglobulin Industry Value Chain
Figure 55. Marketing Channels
